Literature DB >> 32895868

The Effect of Emergency Department Visits and Inflammatory Markers on One-Year Mortality in Patients with Heart Failure.

Ataman Köse1, Ahmet Çelik2, Ersin Altınsoy3, Seyran Bozkurt Babus3, Semra Erdoğan4.   

Abstract

The neurohumoral and inflammatory pathways proposed for the development and progression of heart failure (HF) remain up-to-date. We aimed to investigate the effect of emergency department (ED) visits and inflammatory markers on mortality in HF patients. Two-hundred patients with stable chronic HF followed by the cardiology clinic were included in this study. The patients were divided into two groups as patients who had visited the ED due to worsening HF symptoms within the last 6 months (ED visit Group) and who had not (No ED visit Group). The demographical properties, clinical characteristics, and laboratory values including inflammatory markers of the patients were recorded. During the follow-up period, 38 patients (19%) died. In HF patients with previous ED visits, the mortality risk was 2.091 times higher (relative risk, RR). It was identified that the HF patients who died during the follow-up had higher initial NLR (p = 0.004), IG% (p = 0.029), hs-CRP (p = 0.001), and NT-proBNP (p = 0.004) values. It was observed that the area under the curve (AUC) values, NLR (AUC: 0.705, p < 0.001), IG% (AUC: 0.652, p = 0.003), and hs-CRP (AUC: 0.732, p < 0.001) were very strong predictors of the 1-year mortality. According to the cut-off points, the mortality risk (RR) was 3.39 times higher in patients with NLR > 3.7 (95% CI 1.783-6.444), 2.39 times higher when IG% > 0.4 (95% CI 1.16-4.957), and 4,2 times higher when hs-CRP > 9.9 mg/dl (95% CI 2.16-8.16) (p < 0.05). The patients with chronic stable HF who visited the ED within the last six months and having increased NLR, IG%, and CRP levels among inflammatory markers were associated with a higher mortality risk at 1 year.

Entities:  

Keywords:  Emergency department; Heart failure; Inflammatory markers; Mortality

Year:  2020        PMID: 32895868     DOI: 10.1007/s12012-020-09594-2

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  25 in total

Review 1.  Hormones and hemodynamics in heart failure.

Authors:  R W Schrier; W T Abraham
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  A Test in Context: High-Sensitivity C-Reactive Protein.

Authors:  Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2016-02-16       Impact factor: 24.094

3.  Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.

Authors:  Krista Siirilä-Waris; Johan Lassus; John Melin; Keijo Peuhkurinen; Markku S Nieminen; Veli-Pekka Harjola
Journal:  Eur Heart J       Date:  2006-11-24       Impact factor: 29.983

4.  Physician continuity improves outcomes for heart failure patients treated and released from the emergency department.

Authors:  Robinder S Sidhu; Erik Youngson; Finlay A McAlister
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

5.  Impact of specialist follow-up in outpatients with congestive heart failure.

Authors:  Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

6.  Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.

Authors:  Toru Kondo; Takahiro Okumura; Yuya Matsue; Atsushi Shiraishi; Nobuyuki Kagiyama; Tetsuo Yamaguchi; Shunsuke Kuroda; Keisuke Kida; Atsushi Mizuno; Shogo Oishi; Yasutaka Inuzuka; Eiichi Akiyama; Ryuichi Matsukawa; Kota Kato; Satoshi Suzuki; Takashi Naruke; Kenji Yoshioka; Tatsuya Miyoshi; Yuichi Baba; Masayoshi Yamamoto; Koji Murai; Kazuo Mizutani; Kazuki Yoshida; Takeshi Kitai; Toyoaki Murohara
Journal:  Circ J       Date:  2018-11-15       Impact factor: 2.993

7.  Multicentric investigation of survival after Spanish emergency department discharge for acute heart failure.

Authors:  Oscar Miró; Víctor Gil; Pablo Herrero; Francisco Javier Martín-Sánchez; Javier Jacob; Pere Llorens
Journal:  Eur J Emerg Med       Date:  2012-06       Impact factor: 2.799

8.  International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes.

Authors:  Sean P Collins; Peter S Pang; Christopher J Lindsell; Demetrios N Kyriacou; Alan B Storrow; Judd E Hollander; J Douglas Kirk; Chadwick D Miller; Richard Nowak; W Frank Peacock; Miguel Tavares; Alexandre Mebazaa; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2010-08-25       Impact factor: 15.534

Review 9.  Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review.

Authors:  José Paulo Araújo; Patricia Lourenço; Ana Azevedo; Fernando Friões; Francisco Rocha-Gonçalves; António Ferreira; Paulo Bettencourt
Journal:  J Card Fail       Date:  2008-12-27       Impact factor: 5.712

Review 10.  Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.

Authors:  Stephane Heymans; Emilio Hirsch; Stefan D Anker; Pal Aukrust; Jean-Luc Balligand; Jan W Cohen-Tervaert; Helmut Drexler; Gerasimos Filippatos; Stephan B Felix; Lars Gullestad; Denise Hilfiker-Kleiner; Stefan Janssens; Roberto Latini; Gitte Neubauer; Walter J Paulus; Burkert Pieske; Piotr Ponikowski; Blanche Schroen; Heinz-Peter Schultheiss; Carsten Tschöpe; Marc Van Bilsen; Faiez Zannad; John McMurray; Ajay M Shah
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.